No Data
Verona Pharma Signs Financing Agreements for Up to $650 Million
Verona Pharma (VRNA) said Thursday it signed deals providing up to $650 million in financing from funds managed by Oaktree Capital Management and OMERS Life Sciences. The financing consists of up to $
X4 Pharma Gains on New $125 Financing
Express News | Electric Hydrogen: $100 Mln Credit Facility From HSBC, J.p. Morgan, Stifel Bank and Hercules Capital
Express News | Verona Pharma PLC - Cash Runway Extended Beyond 2026
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
Express News | X4: $125 Mln of Non-Dilutive Capital Extends Projected Cash Runway Into Late 2025, Excluding Expected Commercial Sales From Xolremdi